Literature DB >> 22895702

Characterization of multiple exon 1 variants in mammalian HuD mRNA and neuron-specific transcriptional control via neurogenin 2.

Lucas M Bronicki1, Guy Bélanger, Bernard J Jasmin.   

Abstract

The RBP (RNA-binding protein) and Hu/ELAV family member HuD regulates mRNA metabolism of genes directly or indirectly involved in neuronal differentiation, learning and memory, and several neurological diseases. Given the important functions of HuD in a variety of processes, we set out to determine the mechanisms that promote HuD mRNA expression in neurons using a mouse model. Through several complementary approaches, we determined that the abundance of HuD mRNA is predominantly under transcriptional control in developing neurons. Bioinformatic and 5'RACE (rapid amplification of cDNA ends) analyses of the 5' genomic flanking region identified eight conserved HuD leader exons (E1s), two of which are novel. Expression of all E1 variants was determined in mouse embryonic (E14.5) and adult brains. Sequential deletion of the 5' regulatory region upstream of the predominantly expressed E1c variant revealed a well conserved 400 bp DNA region that contains five E-boxes and is capable of directing HuD expression specifically in neurons. Using EMSA (electrophoretic mobility shift assay), ChIP (chromatin immunoprecipitation), and 5' regulatory region deletion and mutation analysis, we found that two of these E-boxes are targets of Neurogenin 2 (Ngn2) and that this mechanism is important for HuD mRNA induction. Together, our findings reveal that transcriptional regulation of HuD involves the use of alternate leader exons and Ngn2 mediates neuron-specific mRNA expression. To our knowledge, this is the first study to identify molecular events that positively regulate HuD mRNA expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895702      PMCID: PMC6621197          DOI: 10.1523/JNEUROSCI.2247-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

1.  Expression of the utrophin gene during myogenic differentiation.

Authors:  A O Gramolini; B J Jasmin
Journal:  Nucleic Acids Res       Date:  1999-09-01       Impact factor: 16.971

2.  Analysis of the 5' end of the mouse Elavl1 (mHuA) gene reveals a transcriptional regulatory element and evidence for conserved genomic organization.

Authors:  P H King; J J Fuller; L B Nabors; P J Detloff
Journal:  Gene       Date:  2000-01-25       Impact factor: 3.688

3.  Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons.

Authors:  H C Park; C H Kim; Y K Bae; S Y Yeo; S H Kim; S K Hong; J Shin; K W Yoo; M Hibi; T Hirano; N Miki; A B Chitnis; T L Huh
Journal:  Dev Biol       Date:  2000-11-15       Impact factor: 3.582

4.  Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins.

Authors:  A Quattrone; A Pascale; X Nogues; W Zhao; P Gusev; A Pacini; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

5.  The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells.

Authors:  C D Mobarak; K D Anderson; M Morin; A Beckel-Mitchener; S L Rogers; H Furneaux; P King; N I Perrone-Bizzozero
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

6.  Post-transcriptional regulation of acetylcholinesterase mRNAs in nerve growth factor-treated PC12 cells by the RNA-binding protein HuD.

Authors:  Julie Deschenes-Furry; Guy Belanger; Nora Perrone-Bizzozero; Bernard J Jasmin
Journal:  J Biol Chem       Date:  2002-12-04       Impact factor: 5.157

Review 7.  Proneural genes and the specification of neural cell types.

Authors:  Nicolas Bertrand; Diogo S Castro; François Guillemot
Journal:  Nat Rev Neurosci       Date:  2002-07       Impact factor: 34.870

8.  Characterization of two promoters of the Xenopus laevis elrD gene.

Authors:  F Nassar; M Wegnez
Journal:  Biochem Biophys Res Commun       Date:  2001-05-04       Impact factor: 3.575

9.  Molecular mechanisms underlying the activity-linked alterations in acetylcholinesterase mRNAs in developing versus adult rat skeletal muscles.

Authors:  C Boudreau-Larivière; R Y Chan; J Wu; B J Jasmin
Journal:  J Neurochem       Date:  2000-06       Impact factor: 5.372

10.  Domain necessary for Drosophila ELAV nuclear localization: function requires nuclear ELAV.

Authors:  Y M Yannoni; K White
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

View more
  6 in total

1.  Positive feedback between RNA-binding protein HuD and transcription factor SATB1 promotes neurogenesis.

Authors:  Feifei Wang; Joseph J Tidei; Eric D Polich; Yu Gao; Huashan Zhao; Nora I Perrone-Bizzozero; Weixiang Guo; Xinyu Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

Review 2.  Roles of Embryonic Lethal Abnormal Vision-Like RNA Binding Proteins in Cancer and Beyond.

Authors:  Haijian Cai; Dandan Zheng; Yizhu Yao; Lehe Yang; Xiaoying Huang; Liangxing Wang
Journal:  Front Cell Dev Biol       Date:  2022-04-06

Review 3.  RNA-Binding Protein HuD as a Versatile Factor in Neuronal and Non-Neuronal Systems.

Authors:  Myeongwoo Jung; Eun Kyung Lee
Journal:  Biology (Basel)       Date:  2021-04-23

Review 4.  Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction.

Authors:  Lucas M Bronicki; Bernard J Jasmin
Journal:  RNA       Date:  2013-08       Impact factor: 4.942

5.  Small Molecules Modulate Chromatin Accessibility to Promote NEUROG2-Mediated Fibroblast-to-Neuron Reprogramming.

Authors:  Derek K Smith; Jianjing Yang; Meng-Lu Liu; Chun-Li Zhang
Journal:  Stem Cell Reports       Date:  2016-10-27       Impact factor: 7.765

6.  Interaction of HuDA and PABP at 5'UTR of mouse insulin2 regulates insulin biosynthesis.

Authors:  Poonam R Pandey; Rucha D Sarwade; Abdul Khalique; Vasudevan Seshadri
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.